Q32 Bio (QTTB) FCF Margin (QoQ) (2018 - 2023)
Q32 Bio (QTTB) FCF Margin (QoQ) (2018 - 2023) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Q32 Bio | 215.66 Mn | 164.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -6,743.00 |
| Sep 30, 2023 | 121,081.00 |
| Jun 30, 2023 | 6,774.00 |
| Mar 31, 2023 | 296,927.00 |
| Dec 31, 2022 | -28,304.00 |
| Sep 30, 2022 | 88,766.00 |
| Jun 30, 2022 | -16,384.00 |
| Mar 31, 2022 | 25,549.00 |
| Dec 31, 2021 | -266,719.00 |
| Sep 30, 2021 | -26,361.00 |
| Jun 30, 2021 | -105,496.00 |
| Mar 31, 2021 | 102,402.00 |
| Dec 31, 2020 | 408,178.00 |
| Sep 30, 2020 | -62,610.00 |
| Jun 30, 2020 | 15,861.00 |
| Mar 31, 2020 | 369,278.00 |
| Dec 31, 2019 | -621,619.00 |
| Sep 30, 2019 | 614,459.00 |
| Jun 30, 2019 | 20,972.00 |
| Mar 31, 2019 | -660,341.00 |